Exane Derivatives’s Pfizer PFE Stock Holding History

Exane Derivatives’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$709K	Sell	13,531 -7,785	-37%	-$397K	0.41%	56
2022 Q1	$1.1M	Sell	21,316 -819	-4%	-$42.5K	0.31%	77
2021 Q4	$1.31M	Buy	22,135 +2,361	+12%	+$117K	0.32%	64
2021 Q3	$850K	Sell	19,774 -11,435	-37%	-$507K	0.2%	105
2021 Q2	$1.24M	Sell	31,209 -11,701	-27%	-$455K	0.28%	80
2021 Q1	$1.55M	Buy	42,910 +14,132	+49%	+$502K	0.44%	47
2020 Q4	$1.06M	Buy	28,778 +19,269	+203%	+$707K	0.31%	81
2020 Q3	$331K	Sell	9,509 -1,073	-10%	-$37.6K	0.1%	169
2020 Q2	$328K	Sell	10,582 -3,074	-23%	-$104K	0.09%	184
2020 Q1	$423K	Sell	13,656 -1,441	-10%	-$49.1K	0.12%	134
2019 Q4	$582K	Sell	15,097 -4,351	-22%	-$155K	0.11%	155
2019 Q3	$663K	Buy	+19,448	New	+$707K	0.12%	134
2018 Q4	–	Sell	-34,270	Closed	-$1.43M	–	724
2018 Q3	$1.43M	Buy	+34,270	New	+$1.32M	0.27%	86
2018 Q2	–	Sell	-66,406	Closed	-$2.22M	–	697
2018 Q1	$2.22M	Buy	+66,406	New	+$2.28M	0.44%	50
2016 Q1	–	Sell	-21,928	Closed	-$672K	–	608
2015 Q4	$672K	Buy	21,928 +2,369	+12%	+$74.5K	0.09%	102
2015 Q3	$583K	Buy	19,559 +4,258	+28%	+$137K	0.07%	117
2015 Q2	$487K	Buy	15,301 +1,581	+12%	+$51.5K	0.05%	141
2015 Q1	$453K	Sell	13,720 -7,733	-36%	-$246K	0.05%	152
2014 Q4	$634K	Buy	+21,453	New	+$615K	0.09%	125

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Exane Derivatives's PFE Position: Q2 2022 in Review

Exane Derivatives reduced its Pfizer (PFE) stake by 37% in Q2 2022, selling an estimated $397K and leaving 13,531 shares worth $709K. The position accounts for 0.41% of the portfolio, ranked #56.

Exane Derivatives first reported a position in PFE in Q4 2014 and has held it in 19 quarters since. The position peaked at $2.22M in Q1 2018. 3,158 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

Exane Derivatives held 13,531 shares of Pfizer worth $709K as of Q2 2022.
Exane Derivatives sold 7,785 Pfizer shares in Q2 2022, an estimated $397K.
Pfizer made up 0.41% of Exane Derivatives's portfolio in Q2 2022, its #56 holding.
Exane Derivatives first reported a position in Pfizer in Q4 2014 and has held it in 19 quarters since.
Exane Derivatives's Pfizer position peaked at $2.22M in Q1 2018.
3,158 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.